Tag Archives: pharmaceutical funding
Naila Ramji advocates for the importance of clinical trial transparency.
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
Matthew Herder argues that recent drug price hikes are only one part of a bigger problem with industry-driven pharmaceutical research and development.
Abby Lippman, Alana Cattapan, and Kelly Holloway argue for rigorous, conflict-free research into the safety and effectiveness of the HPV vaccine and for a critical approach to its use.
Nicholas G. Evans makes the distinction between being partial and being compromised.